Acknowledgements
The authors like to thank Laura Di Lorenzo and Angelika Sandritter for facilitating the access to the financial records of the Cov-Surv-Study trial and retrieving cost information from the central accounting system. We further thank Matthias Meurer and Daniel Kirrmaier for their provision of information related to the RT-LAMP assay. Additionally, we thank Simon Anders and Svetlana Ovchinnikova for providing information on their time contribution to the development and implementation of the IT solutions and databases of the trial; Hilde Gold, Hannah Palatinus and Sandra Oerther for providing information on their time contribution to the administration, general management and implementation of the trial. Finally, we thank Salvador Shabbir of language editing of the manuscript.